Diff Profiles › MTBLS3628_0005_00000004

Normal_control_no_tumor_vs_FH_deficient_RCC

Normal_control_no_tumor vs FH_deficient_RCC

p-value ≤ 0.05 2 significant 2025-09-26 00:00:00 Study: MTBLS3628
2 Total Features
2 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS3628_0005_00000004
Linked study
MTBLS3628 — Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
Comparison
Normal_control_no_tumor vs FH_deficient_RCC
Group A
Samples from healthy individuals with no tumor.. Provides a reference for identifying metabolic changes specific to RCC.
Group B
Samples from patients with FH-deficient renal cell carcinoma.. Key group for identifying metabolic biomarkers associated with FH-deficient RCC.
Total features tested
2
Significant features
2
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value
XPKKFTKCRVIDAG-UHFFFAOYSA-N 2-(2-amino-2-carboxyethyl)sulanylbutanedioic acid up 39.15 2.82e-06
VKGZCEJTCKHMRL-VWJPMABRSA-N <em>N</em>-(9-β-<small>D</small>-ribofuranosyl-9<em>H</em>-purin-6-yl)-<small>L</small>-aspartic acid up 17.74 0.000249